Skip to main content

Doptelet Side Effects

Generic name: avatrombopag

Medically reviewed by Philip Thornton, DipPharm. Last updated on Aug 24, 2022.

Note: This document contains side effect information about avatrombopag. Some dosage forms listed on this page may not apply to the brand name Doptelet.

Applies to avatrombopag: oral tablet.

Serious side effects of Doptelet

Along with its needed effects, avatrombopag (the active ingredient contained in Doptelet) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking avatrombopag:

Less common

Less common

  • Bloating or swelling of the face, arms, hands, lower legs, or feet
  • rapid weight gain
  • tingling of the hands or feet
  • unusual weight gain or loss

Rare

Incidence not known

  • Difficulty breathing
  • pain in the chest, groin, or legs, especially the calves
  • severe, sudden headache
  • slurred speech
  • sudden loss of coordination
  • sudden, severe weakness or numbness in the arm or leg
  • vision changes

Other side effects of Doptelet

Some side effects of avatrombopag may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Body aches or pain
  • bruise
  • chills
  • cough
  • difficulty in moving
  • ear congestion
  • fever
  • joint pain
  • loss of voice
  • muscle stiffness
  • sneezing
  • sore throat
  • stomach pain
  • stuffy or runny nose

For Healthcare Professionals

Applies to avatrombopag: oral tablet.

General

The most common serious adverse reactions were headache and hyponatremia.[Ref]

Nervous system

Very common (10% or more): Headache (up to 31%)[Ref]

Other

Very common (10% or more): Fatigue (up to 28%), pyrexia (up to 11%)

Common (1% to 10%): Edema peripheral[Ref]

Cardiovascular

Very common (10% or more): Contusion (26%)

Common (1% to 10%): Thromboembolic events

Respiratory

Very common (10% or more): Epistaxis (19%), upper respiratory tract infection (15%), nasopharyngitis (10%)

Postmarketing reports: Choking sensation, pharyngeal edema

Musculoskeletal

Very common (10% or more): Arthralgia (13%)

Frequency not reported: Myalgia[Ref]

Gastrointestinal

Very common (10% or more): Gingival bleeding (13%)

Common (1% to 10%): Abdominal pain, nausea[Ref]

Dermatologic

Very common (10% or more): Petechiae (11%)

Postmarketing reports: Pruritus, rash, erythema, pruritus generalized, rash macular

Metabolic

Uncommon (0.1% to 1%): Hyponatremia[Ref]

Hematologic

Frequency not reported: Anemia

Immunologic

Postmarketing reports: Hypersensitivity reactions, swelling face, swollen tongue

Frequently asked questions

References

1. "Product Information. Doptelet (avatrombopag)." Dova Pharmaceuticals (2018):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.